CPHI 2026: Finding the right CDMO partner in an age of consolidation
Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing.
Comment & Opinion
Suspected plague outbreak in Russia: public health risk lower than Covid-19
CPHI 2026: Moderna builds on its COVID-era manufacturing lessons
EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis
EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis
EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D
China expands its manufacturing role for biopharma’s new drugs
FDA hearing: psychedelics launch needs balanced regulation without limiting access
